PT1390371E - Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores - Google Patents

Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores

Info

Publication number
PT1390371E
PT1390371E PT02740590T PT02740590T PT1390371E PT 1390371 E PT1390371 E PT 1390371E PT 02740590 T PT02740590 T PT 02740590T PT 02740590 T PT02740590 T PT 02740590T PT 1390371 E PT1390371 E PT 1390371E
Authority
PT
Portugal
Prior art keywords
furopyrimidines
oxazolo
against tumors
medicines against
formula
Prior art date
Application number
PT02740590T
Other languages
English (en)
Portuguese (pt)
Inventor
Bold Guido
Manley Paul William
Martin-Kohler Andreas
Sequin Urs
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT1390371E publication Critical patent/PT1390371E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT02740590T 2001-05-14 2002-05-13 Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores PT1390371E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH8732001 2001-05-14

Publications (1)

Publication Number Publication Date
PT1390371E true PT1390371E (pt) 2006-07-31

Family

ID=4544205

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02740590T PT1390371E (pt) 2001-05-14 2002-05-13 Oxazolo- e furopirimidinas e sua utilizacao em medicamentos contra tumores

Country Status (12)

Country Link
US (1) US7294633B2 (cg-RX-API-DMAC10.html)
EP (1) EP1390371B1 (cg-RX-API-DMAC10.html)
JP (1) JP4155827B2 (cg-RX-API-DMAC10.html)
CN (1) CN100378107C (cg-RX-API-DMAC10.html)
AT (1) ATE319718T1 (cg-RX-API-DMAC10.html)
BR (1) BR0209645A (cg-RX-API-DMAC10.html)
CA (1) CA2449188A1 (cg-RX-API-DMAC10.html)
DE (1) DE60209721T2 (cg-RX-API-DMAC10.html)
DK (1) DK1390371T3 (cg-RX-API-DMAC10.html)
ES (1) ES2259707T3 (cg-RX-API-DMAC10.html)
PT (1) PT1390371E (cg-RX-API-DMAC10.html)
WO (1) WO2002092603A1 (cg-RX-API-DMAC10.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1689753A4 (en) * 2003-12-04 2010-07-07 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
KR20050091462A (ko) * 2004-03-12 2005-09-15 한국과학기술연구원 푸로피리미딘 화합물 및 이를 포함하는 ｄｄｒ2 티로신키나아제 활성 저해제
JPWO2005095419A1 (ja) * 2004-04-01 2008-02-21 武田薬品工業株式会社 チアゾロピリミジン誘導体
EP1874769B1 (de) 2005-04-25 2011-09-14 Merck Patent GmbH Neuartige aza-heterozyklen als kinase-inhibitoren
DE102005061170A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
DE102005061171A1 (de) 2005-12-21 2007-07-05 Bayer Healthcare Ag Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung
EP3219319A1 (en) * 2006-06-22 2017-09-20 Nippon Chemiphar Co., Ltd. Agent for overcoming resistance to anti-cancer agent
DE102007019691A1 (de) 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von acyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007019690A1 (de) 2007-04-26 2008-10-30 Bayer Healthcare Ag Verwendung von cyclisch substituierten Furopyrimidin-Derivaten zur Behandlung der pulmonalen arteriellen Hypertonie
DE102007027799A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte Furopyrimidine und ihre Verwendung
DE102007027800A1 (de) 2007-06-16 2008-12-18 Bayer Healthcare Ag Substituierte bicyclische Heteroaryl-Verbindungen und ihre Verwendung
RU2345996C1 (ru) * 2007-07-17 2009-02-10 Андрей Александрович Иващенко Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
EP2318415B1 (en) * 2008-07-15 2013-02-20 Sanofi Oxazolopyrimidines as edg-1 receptor agonists
UY32240A (es) 2008-11-14 2010-06-30 Boeringer Ingelheim Kg Nuevas 2,4-diaminopirimidinas, sus sales farmacéuticamente aceptables, composiciones conteniéndolas y aplicaciones.
CN101899057A (zh) * 2010-07-21 2010-12-01 中国药科大学 嘧啶并噁唑衍生物的一种制备方法及其在医学上的用途
US8907093B2 (en) * 2011-07-07 2014-12-09 Sanofi Carboxylic acid derivatives having an oxazolo[4,5-c]pyridine ring
US8580816B2 (en) * 2011-07-07 2013-11-12 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring
CN103087077B (zh) * 2011-11-03 2016-05-18 上海希迈医药科技有限公司 噻吩并嘧啶和呋喃并嘧啶类衍生物、其制备方法及其在医药上的应用
CN103360407B (zh) * 2012-04-10 2016-06-22 上海希迈医药科技有限公司 一种噻吩并嘧啶类衍生物、其制备方法及其在医药上的应用
WO2015162518A1 (en) 2014-04-25 2015-10-29 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands
CN104650111A (zh) * 2015-01-14 2015-05-27 中国药科大学 芳基脲及芳基酰胺取代的噁唑并嘧啶类化合物及其制备和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137879A (en) 1990-03-30 1992-08-11 Dowelanco Furopyrimidin-4-imine derivatives
US5227387A (en) * 1991-09-03 1993-07-13 Dowelanco Quinoline nematicidal method
ES2109796T3 (es) 1994-05-03 1998-01-16 Ciba Geigy Ag Derivados de pirrolopirimidilo con efecto antiproliferante.
JPH1184248A (ja) * 1997-09-12 1999-03-26 Nikon Corp 反射屈折縮小光学系
KR100600550B1 (ko) * 2000-10-20 2006-07-13 에자이 가부시키가이샤 질소 함유 방향환 유도체

Also Published As

Publication number Publication date
US20040152892A1 (en) 2004-08-05
CN1509291A (zh) 2004-06-30
ES2259707T3 (es) 2006-10-16
DK1390371T3 (da) 2006-06-19
WO2002092603A1 (en) 2002-11-21
JP4155827B2 (ja) 2008-09-24
BR0209645A (pt) 2004-07-06
EP1390371B1 (en) 2006-03-08
DE60209721D1 (de) 2006-05-04
JP2005508855A (ja) 2005-04-07
CA2449188A1 (en) 2002-11-21
US7294633B2 (en) 2007-11-13
ATE319718T1 (de) 2006-03-15
EP1390371A1 (en) 2004-02-25
DE60209721T2 (de) 2006-09-07
CN100378107C (zh) 2008-04-02

Similar Documents

Publication Publication Date Title
ATE411022T1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
DE50310516D1 (de) Fredericamycin-derivate
ATE452129T1 (de) N-phenyl-2-pyrimidine-amine derivatives
SE0101387D0 (sv) Novel compounds
BR0308787A (pt) Inibidores de metaloproteinase de n-substituìdos-heteroarilóxi-aril-espiro-pirimidina- 2,4,6-triona
BR0209645A (pt) Oxazolo- e furopirimidinas e seu uso como medicamentos
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
ATE341550T1 (de) Quinolinyl-pyrrolopyrazole
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
ATE497770T1 (de) Pharmazeutische formulierungen von decitabin
ATE448232T1 (de) Substituierte heterozyklen
ATE396986T1 (de) Pyrimidylpyrrolderivate, die als kinaseinhibitoren wirken
JO2764B1 (en) Indole derivatives or benzimidazole derivatives to modify the enzyme AKP kinase
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
SE0300098D0 (sv) Use of cyclin D1 inhibitors
NO20050640L (no) Rutenium anticancer komplekser
DE60315288D1 (de) Cyanoguanidin prodrugs
SE9802209D0 (sv) Novel compounds
TW200504051A (en) Novel acridine derivatives and their use as medicaments
SE0004827D0 (sv) Therapeutic compounds
NO20055650D0 (no) Ruteinum (II)-komplekser for behandling av tumorer